Sale!

KCNA1 Gene Episodic ataxia type 1 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCNA1 Gene Episodic Ataxia Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the KCNA1 gene, which are linked to Episodic Ataxia Type 1 (EA1). EA1 is a rare genetic disorder characterized by brief episodes of ataxia, or lack of muscle coordination, often accompanied by myokymia (involuntary muscle twitching). These episodes can be triggered by stress, sudden movements, or physical exertion.

The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic alterations in the KCNA1 gene. Identifying these mutations can confirm a diagnosis of EA1, enabling targeted management and treatment strategies for affected individuals.

The cost of the KCNA1 Gene Episodic Ataxia Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the relevant genetic mutations, offering invaluable insights for patients and their families. By confirming a diagnosis, the test can facilitate informed decisions regarding treatment options, potential lifestyle adjustments, and genetic counseling for family planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNA1 Gene Episodic ataxia type 1 Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for KCNA1 Gene Episodic ataxia type 1 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with KCNA1 Gene Episodic ataxia type 1

Test Details:

Episodic ataxia type 1 (EA1) is a rare genetic disorder that affects the nervous system, causing episodes of uncoordinated movement and muscle weakness. The KCNA1 gene is responsible for producing a protein that regulates the flow of potassium ions in nerve cells. Mutations in this gene can disrupt this process, leading to the symptoms of EA1.

NGS (Next Generation Sequencing) genetic testing is a method of analyzing DNA that allows for the detection of mutations in multiple genes simultaneously. This technology can be used to identify mutations in the KCNA1 gene that are associated with EA1.

The KCNA1 gene NGS genetic test involves collecting a sample of DNA from the patient, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations in the KCNA1 gene.

The results of the test can help diagnose EA1 and provide information about the patient’s risk of passing the condition on to their children. Genetic testing can also be used to inform treatment decisions and provide guidance for genetic counseling. However, it is important to note that not all mutations in the KCNA1 gene are associated with EA1, and a negative test result does not necessarily rule out the possibility of the condition. A comprehensive evaluation by a medical professional is recommended for anyone experiencing symptoms of EA1.

Test Name KCNA1 Gene Episodic ataxia type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNA1 Gene Episodic ataxia type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNA1 Gene Episodic ataxia type 1
Test Details

Episodic ataxia type 1 (EA1) is a rare genetic disorder that affects the nervous system, causing episodes of uncoordinated movement and muscle weakness. The KCNA1 gene is responsible for producing a protein that regulates the flow of potassium ions in nerve cells. Mutations in this gene can disrupt this process, leading to the symptoms of EA1.

NGS (Next Generation Sequencing) genetic testing is a method of analyzing DNA that allows for the detection of mutations in multiple genes simultaneously. This technology can be used to identify mutations in the KCNA1 gene that are associated with EA1.

The KCNA1 gene NGS genetic test involves collecting a sample of DNA from the patient, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations in the KCNA1 gene. The results of the test can help diagnose EA1 and provide information about the patient’s risk of passing the condition on to their children.

Genetic testing can also be used to inform treatment decisions and provide guidance for genetic counseling. However, it is important to note that not all mutations in the KCNA1 gene are associated with EA1, and a negative test result does not necessarily rule out the possibility of the condition. A comprehensive evaluation by a medical professional is recommended for anyone experiencing symptoms of EA1.